Advertisement

International Journal of Behavioral Medicine

, Volume 13, Issue 3, pp 214–220 | Cite as

Effects of fasting therapy on irritable bowel syndrome

  • Motoyori Kanazawa
  • Shin Fukudo
Article

Abstract

How to treat patients with irritable bowel syndrome (IBS) who do not respond to pharmacotherapy is an unsolved problem. Psychotherapy, which has been reported on in previous studies, is available only in specific centers. We describe in this study a novel and simple psychotherapy; that is, the fasting therapy (FT) for treatment of patients with IBS. Of 84 inpatients with IBS, 58 patients who still had moderate to severe IBS symptoms after 4-week basic treatment were investigated retrospectively. Of the 58 patients enrolled in this study, 36 underwent FT, whereas the remaining 22 received a consecutive basic treatment (control therapy). There were no significant differences in the 4-point severity scales of gastrointestinal and psychological symptoms between the 2 groups before the start of FT. The basic treatment consisted of pharmacotherapy and brief psychotherapy, whereas the FT consisted of 10 days of starvation followed by 5 days of refeeding. Changes in scores of symptoms before and after each treatment were analyzed. FT significantly improved 7 out of the 10 symptoms assessed; that is, abdominal pain-discomfort (p < .001), abdominal distension (p < .001), diarrhea (p < .001), anorexia (p = .02), nausea (p < .01), anxiety (p < .001), and interference with life in general (p < .001). However, the control therapy significantly improved only 3 out of the 10 symptoms assessed; that is, abdominal pain-discomfort (p = .03), abdominal distension (p < .01), and interference with life (p = .01). Our results suggest that FT may have beneficial effects on intractable patients with IBS.

Key words

irritable bowel syndrome fasting therapy psychotherapy starvation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders (3rd ed.). Washington, DC: Author.Google Scholar
  2. American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed., Rev. ed.). Washington, DC: Author.Google Scholar
  3. Anderson, R. (1984). The immunostimulatory, anti-inflammatory and anti-allergic properties of ascorbate. Advances in Nutritional Research, 6, 19–45.PubMedGoogle Scholar
  4. Atkinson, W., Sheldon, T. A., Shaath, N., & Whorwell, P. J. (2004). Food elimination based on IgG antibodies in irritable bowel syndrome: A randomized controlled trial. Gut, 53, 1459–1464.PubMedCrossRefGoogle Scholar
  5. Bennet, P., & Wilkinson, S. (1985). A comparison of psychological and medical treatment in the irritable bowel syndrome. British Journal of Clinical Psychology, 24, 215–216.Google Scholar
  6. Bentley, S. J., Pearson, D. J., & Rix, K. J. B. (1983). Food hypersensitivity in irritable bowel syndrome. Lancet, 2, 295–297.PubMedCrossRefGoogle Scholar
  7. Benton, D., Griffiths, R., & Haller, J. (1997). Thiamine supplementation mood and cognitive function. Psychopharmacology, 129, 66–71.PubMedCrossRefGoogle Scholar
  8. Brody, S. (2002). High-dose ascorbic acid increases intercourse frequency and improves mood: A randomized controlled clinical trial. Biological Psychiatry, 15, 371–374.CrossRefGoogle Scholar
  9. Bueno, L., Fioramonti, J., & Ruckebusch, Y. (1977). Mechanisms of propulsion in the small intestine. Annales de Recherches Veterinaires, 8, 293–301.PubMedGoogle Scholar
  10. Drossman, D. A., Camilleri, M., Mayer, E. A., & Whitehead, W. E. (2002). AGA technical review on irritable bowel syndrome. Gastroenterology, 123, 2108–2131.PubMedCrossRefGoogle Scholar
  11. Faulkner, G., Soundy, A. A., & Lloyd, K. (2003). Schizophrenia and weight management: A systemic review of interventions to control weight. Acta Psychiatrica Scandinavica, 108, 324–332.PubMedCrossRefGoogle Scholar
  12. Finn, R., Smith, M. A., Youngs, G. R, Chew, D., Johnson, P. M., & Barnes, R. M. (1987). Immunological hypersensitivity to environmental antigens in the irritable bowel syndrome. British Journal of Clinical Practice, 41, 1041–1043.PubMedGoogle Scholar
  13. Fischer, N. (1967). Obesity, affect, and therapeutic starvation. Archives of General Psychiatry, 17, 227–233.PubMedGoogle Scholar
  14. Gohler L., Hahnemann, T., Michael, N., Oehme, P., Steglich, H. D., Conradi, E., et al. (2000). Reduction of plasma catecholamines in humans during clinically controlled severe underfeeding. Preventive Medicine, 30, 95–102.PubMedCrossRefGoogle Scholar
  15. Guthrie, E., Creed, F., Dawson, D., & Tomenson, B. (1991). A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterology, 100, 450–457.PubMedGoogle Scholar
  16. Hasselbalch, S. G., Knudsen, G. M., Jacobsen, J., Hageman, L. P., Holm, S., & Paulson, O. B. (1994). Brain metabolism during short-term starvation in humans. Journal of Cerebral Blood Flow Metabolism, 14, 125–131.PubMedGoogle Scholar
  17. Kanazawa, M., Endo, Y., Whitehead, W. E., Kano, M., Hongo, M., & Fukudo, S. (2004). Patients and nonconsulters with irritable bowel syndrome reporting a parental history of bowel problems have more impaired psychological distress. Digestive Diseases and Sciences, 49, 1046–1053.PubMedCrossRefGoogle Scholar
  18. Kano, M., Fukudo, S., Kanazawa, M., Endo, Y., Narita, H., Tamura, D., et al. (2006). Changes in intestinal motility, visceral sensitivity and minor mucosal inflammation after fasting therapy in a patient with irritable syndrome: A case report. Journal of Gastroenterology and Hepatology, 21, 1078–1079.PubMedCrossRefGoogle Scholar
  19. Kollar, E. J., & Atkinson, R. M. (1966). Responses of extremely obese patients to starvation. Psychosomatic Medicine, 28, 227–246.PubMedGoogle Scholar
  20. Komaki, G., Tamai, H., Sumioki, H., Mori, T., Kobayashi, N., Mori, K., et al. (1990). Plasma beta-endorphin during fasting in man. Hormone Research, 33, 239–243.PubMedGoogle Scholar
  21. Kunz, R., & Oxman, A. D. (1998). The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials. British Medical Journal, 31, 1185–1190.Google Scholar
  22. Lydiard, R. B. (1997). Anxiety and the irritable bowel syndrome: psychiatric, medical, or both? Journal of Clinical Psychiatry, 58, 51–58.PubMedGoogle Scholar
  23. Manning, A. P., Thompson, W. G., Heaton, K. W., & Morris, A. F. (1978). Towards positive diagnosis of the irritable bowel syndrome. British Medical Journal, 2, 653–654.PubMedCrossRefGoogle Scholar
  24. Milner, G. (1963). Ascorbic acid in chronic psychiatric patients: A controlled trial. British Journal of Psychiatry, 109, 294–299.CrossRefGoogle Scholar
  25. Molina, P. E., Hashiguchi, Y., Meijerink, W. J., Naukam, R. J., Boxer, R., & Abumrad, N. N. (1995). Modulation of endogenous opiate production: Effect of fasting. Biochemical and Biophysical Research Communications, 207, 312–317.PubMedCrossRefGoogle Scholar
  26. Niec, A. M., Frankum, B., & Talley, N. J. (1998). Are adverse food reaction linked to irritable bowel syndrome? American Journal of Gastroenterology, 93, 2184–2190.PubMedCrossRefGoogle Scholar
  27. O’Connor, K. P., Marchand, A., Belanger, L., Mainguy, N., Landry, P., Savard, P., et al. (2004). Psychological distress and adaptational problems associated with benzodiaz epine withdrawal and outcome: A replication. Addictive Behaviors, 29, 583–593.PubMedCrossRefGoogle Scholar
  28. Sandler, R. S. (1990). Epidemiology of irritable bowel syndrome in the United States. Gastroenterology, 99, 409–415.PubMedGoogle Scholar
  29. Simon, G. E., Von Korff, M., Wagner, E. H., & Barlow, W. (1993). Patterns of antidepressant use in community practice. General Hospital Psychiatry, 15, 399–408.PubMedCrossRefGoogle Scholar
  30. Skoldstam, L., & Magnusson, K. E. (1991). Fasting, intestinal permeability, and rheumatoid arthritis. Rheumatic Diseases Clinics North America, 17, 363–371.Google Scholar
  31. Stewart, R. L. (1985). Psychoanalysis and psychoanalytic psychotherapy. In H. I. Kaplan & B. J. Sadock (Eds.), Comprehensive textbook of psychiatry (4th ed., pp. 1331–1365). Baltimore: Williams & Wilkins.Google Scholar
  32. Suzuki, J., Yamamoto, H., & Komuro, U. (1979). Fasting therapy for psychosomatic disorders in Japan. Psychotherapy and Psychosomatics, 31, 307–314.PubMedGoogle Scholar
  33. Suzuki, J., Yamauchi, Y., Horikawa, M., & Yamagata, S. (1976). Fasting therapy for psychosomatic diseases with special reference to its indication and therapeutic mechanism. Tohoku Journal of Experimental Medicine, 118, 245–259.PubMedCrossRefGoogle Scholar
  34. Svedlund, J., Sjodin, I., Ottosson, J., & Dotevall, G. (1983). Controlled study of psychotherapy in irritable bowel syndrome. Lancet, 10, 589–592.CrossRefGoogle Scholar
  35. Talley, N. J., Owen, B. K., Boyce, P., & Paterson, K. (1996). Psychological treatments for irritable bowel syndrome: A critique of controlled treatment trials. American Journal of Gastroenterology, 91, 277–283.PubMedGoogle Scholar
  36. Thompson, W. G., Dotevall, G., Drossman, D. A., Heaton, K. W., & Kruis, W. (1989). Irritable bowel syndrome: Guidelines for the diagnosis. Gastroenterology International, 2, 92–95.Google Scholar
  37. Toner, B. B., Segal, Z. V., Emmott, S., Myran, D., Ali, A., DiGasbarro, I., et al. (1998). Cognitive-behavioral group therapy for patients with irritable bowel syndrome. International Journal of Group Psychotherapy, 48, 215–243.PubMedGoogle Scholar
  38. Whitehead, W. E., & Crowell, M. D. (1991). Psychologic considerations in the irritable bowel syndrome. Gastroenterology Clinics of North America, 20, 249–267.PubMedGoogle Scholar
  39. Whorwell, P. J., Prior, A., & Faragher, E. B. (1984). Controlled trial of hypnotherapy in the treatment of severe refractory irritable bowel syndrome. Lancet, 2, 1232–1234.PubMedCrossRefGoogle Scholar
  40. Yamamoto, H., Suzuki, J., & Yamauchi, Y. (1979). Psychophysiological study on fasting therapy. Psychotherapy and Psychosomatics, 32, 229–240.PubMedCrossRefGoogle Scholar

Copyright information

© International Society of Behavioral Medicine 2006

Authors and Affiliations

  1. 1.Department of Behavioral MedicineTohoku University Graduate School of MedicineAoba, SendaiJapan

Personalised recommendations